Graybug Vision Collaborator Dr. Peter Campochiaro Presented at ARVO 2016
REDWOOD CITY, CA -- (Marketwired) -- 05/02/16 -- Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases including wet age-related macular degeneration (AMD) and glaucoma …